Friday, December 29, 2017

Lupin gets USFDA approval for Dovonex scalp solutions

Lupin has received USFDA approval for its generic version of Dovonex scalp solution used in treatment of psoriasis of scalp.

Lupin closed at Rs 885, up Rs 10 in yesterday's trading.

No comments:

Post a Comment